Abstract

Stringent regulatory standards apply to the creation of Common Technical Documents (CTD) and Electronic Common Technical Documents (eCTD) for regulatory submissions in India, which are overseen by the Central Drugs Standard Control Organization (CDSCO). The essential regulatory considerations affecting the creation of CTD and eCTD submissions in accordance with CDSCO criteria are summarized in this abstract. It emphasizes how crucial adherence to these rules is to ensure the prompt and effective registration of pharmaceutical goods in India. The advantages of eCTD in simplifying the regulatory process are also briefly covered in the abstract, along with the changing environment of electronic submissions. For pharmaceutical businesses seeking market authorisation in India and for regulators striving to maintain the highest standards, understanding and adherence to CDSCO's regulatory requirements are essential.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call